These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Failure of whole blood cyclosporine levels to provide a reliable measure of immunosuppression in clinical heart and heart/lung transplantation. White D; Rose M; Wright L; Wallwork J; English TA; Hakim M; Hutter J Transplant Proc; 1988 Apr; 20(2 Suppl 2):422-5. PubMed ID: 3129845 [No Abstract] [Full Text] [Related]
23. Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo. Borel JF Pharmacol Rev; 1990 Sep; 41(3):259-371. PubMed ID: 2185490 [No Abstract] [Full Text] [Related]
24. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants. Nizze H; Mihatsch MJ; Zollinger HU; Brocheriou C; Gokel JM; Henry K; Sloane JP; Stovin PG Clin Nephrol; 1988 Nov; 30(5):248-60. PubMed ID: 3063420 [TBL] [Abstract][Full Text] [Related]
31. The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine. Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA Transplant Proc; 1988 Jun; 20(3 Suppl 3):1038-44. PubMed ID: 2968694 [No Abstract] [Full Text] [Related]
32. Immunosuppression for cardiac transplantation--the past, present and future. O'Neill JO; Taylor DO; Starling RC Transplant Proc; 2004 Mar; 36(2 Suppl):309S-313S. PubMed ID: 15041359 [TBL] [Abstract][Full Text] [Related]
33. [Personal experience with immunosuppression with cyclosporin A in kidney transplantation]. Bosković S Acta Chir Iugosl; 1989; 36(1):67-81. PubMed ID: 2652959 [TBL] [Abstract][Full Text] [Related]
34. Are steroids essential for successful maintenance of immunosuppression in heart transplantation? Katz MR; Barnhart GR; Szentpetery S; Rider S; Thompson JA; Hess M; Hastillo A; Lower RR J Heart Transplant; 1987; 6(5):293-7. PubMed ID: 3316555 [TBL] [Abstract][Full Text] [Related]
35. Temporal effect of cyclosporine immunosuppression on T lymphocyte subsets, Ia-reactive cells, and donor-specific immunity in cardiac allograft recipients. Mazaheri R; Stiller CR; Keown P; McKenzie N; Howson W; Farrow K; McFarlane D; Sinclair NR Transplant Proc; 1984 Dec; 16(6):1537-9. PubMed ID: 6390861 [No Abstract] [Full Text] [Related]
36. Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporine. Babany G; Morris RE; Babany I; Kates RE J Pharmacol Exp Ther; 1988 Jan; 244(1):259-62. PubMed ID: 3275773 [TBL] [Abstract][Full Text] [Related]
38. Cyclosporine coverage during the risk period leads to 100% long-term graft acceptance in the rat. Lim SM; White DJ; Calne RY Transplant Proc; 1988 Jun; 20(3 Suppl 3):1013-5. PubMed ID: 3291211 [No Abstract] [Full Text] [Related]
39. Orthotopic and heterotopic transplantation of the heart: the Cape Town experience. Cooper DK Ann R Coll Surg Engl; 1984 Jul; 66(4):228-34. PubMed ID: 6378042 [TBL] [Abstract][Full Text] [Related]
40. Effects of low-dose cyclosporine A on toxicity and rejection in cardiac transplantation. Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP Transplant Proc; 1987 Apr; 19(2):2847-50. PubMed ID: 3551225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]